Navigation Links
Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model

RALEIGH, N.C., Sept. 5 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that leaders from its Sales Practice will conduct two speaking engagements at the Center for Business Intelligence's (CBI) Leadership Summit on Evolving the Pharma Sales Model, to be held September 8 and 9, 2008, at the Doubletree Hotel in Philadelphia, PA.

An award-winning sales professional before becoming a pharmaceutical and biotech consultant, Garry O'Grady, Senior Vice President, will open the conference with a session on initiatives that drive sales excellence, and Scott Isaac, Associate Practice Executive, will present an interactive pre- conference workshop on improving the specialty sales model.

Mr. O'Grady's session, titled "Sales Excellence -- The Top 10 Initiatives That Drive Success in a Competitive Selling Environment," will be conducted on Monday, September 8, from 1:15 pm to 2:00 pm. The session will outline the top 10 sales excellence initiatives that help manufacturers succeed in the increasingly complex selling environment and examine three essential initiatives in detail: developing innovative sales models, achieving coaching excellence, and enhancing quality of interactions with customers.

"Today's selling environment is characterized by a number of trends that are making it increasingly difficult for manufacturers to maximize promotional investments," said Mr. O'Grady. "In order to obtain the greatest return on these investments, companies must aggressively pursue new approaches that allow them to create incremental value, improve portfolio potential, and gain competitive differentiation."

Between his service as an officer in the United States Army and joining Campbell Alliance 8 years ago, Mr. O'Grady was a member of the Surgical Products Division of Olympus America, Inc. As a salesperson on the division's Urology Products Marketing Team, he distinguished himself as a member of Olympus's top sales group. Mr. O'Grady also served as a sales representative for Ciba-Geigy and was a member of Ciba's Circle of Excellence. Mr. O'Grady received his MBA from the University of North Carolina at Chapel Hill and earned his BS from the United States Military Academy, West Point.

Earlier in the day, from 8:30 am to 12:00 pm, Mr. Isaac will present a workshop titled "Optimize the Specialty Sales Model - Leverage Smaller Sales Forces and Align Selling Strategies to Specialty and Hospital Environments." The workshop will examine key components of the specialty sales model, as well as common challenges facing each component and best practices to optimally address them. Mr. Isaac will also discuss current industry trends and resulting implications for future sales force strategy development.

"The truth of the matter is that there is no best specialty sales force model," said Mr. Isaac. "Each sales force is different and faces its own unique challenges. The ability to recognize this and know how to address the various components of each specialty force is key to success in the field."

Mr. Isaac brings to Campbell Alliance more than 11 years of pharmaceutical industry experience, including six years managing sales force automation implementations. Having developed many innovative technical solutions to drive sales and collect market intelligence, Mr. Isaac uses his unique sales experience and skills to serve Campbell Alliance's clients. Mr. Isaac holds an MBA with distinction from New York University's Stern School of Business and a BS in Management Information Systems from Binghamton University.

For more information on CBI's Leadership Summit on Evolving the Pharma Sales Model, please visit

Executives from Campbell Alliance speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company's online conference calendar at

About the Sales Practice at Campbell Alliance

A combination of quantitative and qualitative factors must be addressed to get maximum sales force effectiveness, whether you're dealing with a large primary care team or a small specialty sales group. These factors include
-- Deployment (targeting, size, structure, alignment)

-- Support (marketing support, communications, sales force automation)

-- Motivation (incentive compensation, recognition, professional

development, confidence in management)

-- Ability (recruiting, training, assessment)

The Sales Practice at Campbell Alliance helps pharmaceutical and biotech companies take a total approach to sales force optimization-and realize superior sales results-through service offerings such as sales strategy, sales analytics, sales force effectiveness, sales training, and sales force assessment.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit


James Forte

Director, Public and Media Relations

Campbell Alliance

+1 919 844 7100, extension 7195

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
2. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
3. Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry
4. Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting
5. Campbell Alliance Trade and Distribution Practice to Speak at CBIs Commercial Contracts and Chargeback Management Conference
6. Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference
7. Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe
8. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
9. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
10. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
11. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... International ... and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. ... 2015, where ISPE hosted the largest number of attendees in more than a ...
(Date:11/24/2015)... Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider of ... , today announced that the company has set a new quarterly ... quarter on quarter growth posted for Q3 of 2014 to Q3 ... Mexico , with the establishment of an ... --> United Kingdom and ...
(Date:11/24/2015)... PA (PRWEB) , ... November 24, 2015 , ... This ... entrepreneurs at competitive events in five states to develop and pitch their BIG ideas ... projects from each state are competing for votes to win the title of SAP's ...
(Date:11/24/2015)... , November 24, 2015 SHPG ) ... participate in the Piper Jaffray 27 th Annual Healthcare Conference ... December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... Chief Financial Officer, will participate in the Piper Jaffray 27 th ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. EST ...
Breaking Biology Technology:
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
Breaking Biology News(10 mins):